Segment Information (Tables)

3 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Summary of Information by Reportable Segments

The following table presents information about the Company’s reportable segments for the three months ended March 31, 2021 and 2020 (in thousands):

	Three Months Ended March 31,
	2021									2020
	Sorrento Therapeutics			Scilex			Total			Sorrento Therapeutics			Scilex			Total
External revenues	$	7,269		$	6,986		$	14,255		$	2,510		$	5,211		$	7,721
Operating expenses		81,877			17,283			99,160			33,248			17,636			50,884
Operating loss		(74,608	)		(10,297	)		(84,905	)		(30,738	)		(12,425	)		(43,163	)
Unrestricted cash		31,109			10,569			41,678			11,777			10,120			21,897